Exact Mass: 548.2853

Exact Mass Matches: 548.2853

Found 500 metabolites which its exact mass value is equals to given mass value 548.2853, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Cymarin

(3S,5S,8R,9S,10S,13R,14S,17R)-5,14-dihydroxy-3-[(2R,4S,5R,6R)-5-hydroxy-4-methoxy-6-methyl-tetrahydropyran-2-yl]oxy-13-methyl-17-(5-oxo-2H-furan-3-yl)-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-10-carbaldehyde

C30H44O9 (548.2985)

Cymarin is a cardenolide glycoside. Cymarin is a natural product found in Apocynum cannabinum, Adonis amurensis, and other organisms with data available. A cardiotonic cardiac glycoside found in STROPHANTHUS. The aglycone is STROPHANTHIN. C - Cardiovascular system > C01 - Cardiac therapy > C01A - Cardiac glycosides > C01AC - Strophanthus glycosides D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002301 - Cardiac Glycosides D020011 - Protective Agents > D002316 - Cardiotonic Agents > D013328 - Strophanthins D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents

Antimycin A

N-{7-hexyl-4,9-dimethyl-8-[(3-methylbutanoyl)oxy]-2,6-dioxo-1,5-dioxonan-3-yl}-2-hydroxy-3-[(hydroxymethylidene)amino]benzene-1-carboximidate

C28H40N2O9 (548.2734)

D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents D000890 - Anti-Infective Agents > D000935 - Antifungal Agents

Archangelolide

C29H40O10 (548.2621)

ST 27:0;O6;S

(24R)-3alpha,7alpha,12alpha,24,26-pentahydroxy-5beta-cholestan-27-yl hydrogen sulfate

C27H48O9S (548.3019)

Tamoxifen-N-glucuronide

(2R,3R,4S,5S,6S)-6-carboxy-N-(2-{4-[(1Z)-1,2-diphenylbut-1-en-1-yl]phenoxy}ethyl)-3,4,5-trihydroxy-N,N-dimethyloxan-2-aminium

C32H38NO7 (548.2648)

Tamoxifen-N-glucuronide is a metabolite of tamoxifen. Tamoxifen is an antagonist of the estrogen receptor in breast tissue via its active metabolite, hydroxytamoxifen. In other tissues such as the endometrium, it behaves as an agonist, and thus may be characterized as a mixed agonist/antagonist. Tamoxifen is the usual endocrine therapy for hormone receptor-positive breast cancer in pre-menopausal women, and is also a standard in post-menopausal women although aromatase inhibitors are also frequently used in that setting. (Wikipedia)

MPPa (Methyl pyropheophorbide-a)

methyl 3-{16-ethenyl-11-ethyl-4-hydroxy-12,17,21,26-tetramethyl-7,23,24,25-tetraazahexacyclo[18.2.1.1^{5,8}.1^{10,13}.1^{15,18}.0^{2,6}]hexacosa-1,4,6,8(26),9,11,13(25),14,16,18(24),19-undecaen-22-yl}propanoate

C34H36N4O3 (548.2787)

Murabutide

butyl 4-carbamoyl-2-[2-(2-{[3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy}propanamido)propanamido]butanoate

C23H40N4O11 (548.2693)

Trh-gly-lys

2,5-Diamino-3-[4-amino-1-(5-hydroxy-3,4-dihydro-2H-pyrrol-2-yl)-1-oxobutan-2-yl]-2-(2-aminoacetyl)-6-(1H-imidazol-5-yl)-4-oxo-3-(pyrrolidine-2-carbonyl)hexanoate

Clerodendrin G

C29H40O10 (548.2621)

[7R(R)]-7-Deoxo-16-hydroxy-7-(1-hydroxyethyl)verrucarin A

C29H40O10 (548.2621)

Myristinin A

trans-(+)-1-[3-[3,4-Dihydro-7-hydroxy-2-(4-hydroxyphenyl)-2H-1-benzopyran-4-yl]-2,4,6-trihydroxyphenyl]-1-dodecanone

C33H40O7 (548.2774)

Baccharin B2

[4R,7R(S),8R]-7-Deoxo-2-deoxy-4,8-dihydroxy-7-(1-hydroxyethyl)verrucarin A

C29H40O10 (548.2621)

Baccharin B 3

Deacetyltanghinin

C30H44O9 (548.2985)

(3beta,5beta,16beta)-3-[(2,6-dideoxy-beta-D-ribo-hexopyranosyl)oxy]-14,16-dihydroxycard-20(22)-enolide 16-formate|16-formate 3beta-digitoxosylgitoxigenin|3beta-(beta-D-ribo-2,6-dideoxy-hexopyranosyloxy)-16beta-formyloxy-14-hydroxy-5beta,14beta-card-20(22)-enolide|3beta-(beta-D-ribo-2,6-Didesoxy-hexopyranosyloxy)-16beta-formyloxy-14-hydroxy-5beta,14beta-card-20(22)-enolid|gitoxigenin 16beta-formate 3beta-digitoxoside

C30H44O9 (548.2985)

asterriquinone SU5504

C35H36N2O4 (548.2675)

Casearin M

C30H44O9 (548.2985)

scutalpin B

C29H40O10 (548.2621)

(11S)-6-acetyl-124-methoxy-13-oxa-1,6,10,21-tetraaza-12(1,3),14(1,4)-dibenzena-bicyclo[9.6.6]tricosaphan-15c-ene-17,22-dione|Chaenorhin|Chaenorhine|chaenorrhine|chenorhine|chenorrhine

C31H40N4O5 (548.2999)

18,20-epoxycalotropin

C29H40O10 (548.2621)

Met Thr Asn Leu Gly

C22H40N6O8S (548.2628)

3-(2-Hydroxyethyl) thio withaferin A

C30H44O7S (548.2808)

Animicin A

Antimycin A

C28H40N2O9 (548.2734)

relative retention time with respect to 9-anthracene Carboxylic Acid is 1.578 D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents D000890 - Anti-Infective Agents > D000935 - Antifungal Agents relative retention time with respect to 9-anthracene Carboxylic Acid is 1.579 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.582

MLS002695970-01!

C30H44O9 (548.2985)

Antimycin A

antimycin A1

C28H40N2O9 (548.2734)

D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents D000890 - Anti-Infective Agents > D000935 - Antifungal Agents A nine-membered bis-lactone having methyl substituents at the 2- and 6-positions, an n-hexyl substituent at the 8-position, an acyloxy substituent at the 7-position and an aroylamido substituent at the 3-position. It is produced by Streptomyces bacteria and has found commercial use as a fish poison.

1-[2,4,6-trihydroxy-3-[7-hydroxy-2-(4-hydroxyphenyl)-3,4-dihydro-2H-chromen-4-yl]phenyl]dodecan-1-one

NCGC00384734-01!1-[2,4,6-trihydroxy-3-[7-hydroxy-2-(4-hydroxyphenyl)-3,4-dihydro-2H-chromen-4-yl]phenyl]dodecan-1-one

C33H40O7 (548.2774)

C29H40O10_7aH,13aH-Cyclopenta[7,8]phenanthro[2,3-b]pyrano[3,2-e][1,4]dioxin-13a-carboxaldehyde, 1-(2,5-dihydro-5-oxo-3-furanyl)eicosahydro-1,3a,11,11a-tetrahydroxy-9,15a-dimethyl-, (1S,3aS,3bR,6aR,9R,11R,11aS,12aR,13aR,15aS)

NCGC00385528-01_C29H40O10_7aH,13aH-Cyclopenta[7,8]phenanthro[2,3-b]pyrano[3,2-e][1,4]dioxin-13a-carboxaldehyde, 1-(2,5-dihydro-5-oxo-3-furanyl)eicosahydro-1,3a,11,11a-tetrahydroxy-9,15a-dimethyl-, (1S,3aS,3bR,6aR,9R,11R,11aS,12aR,13aR,15aS)-

C29H40O10 (548.2621)

C30H44O9_(3beta,5beta,8xi,9xi,17alpha)-3-[(6-Deoxy-3-O-methyl-alpha-L-glucopyranosyl)oxy]-14-hydroxy-19-oxocard-20(22)-enolide

NCGC00384656-01_C30H44O9_(3beta,5beta,8xi,9xi,17alpha)-3-[(6-Deoxy-3-O-methyl-alpha-L-glucopyranosyl)oxy]-14-hydroxy-19-oxocard-20(22)-enolide

MLGQT

Met-Leu-Gly-Gln-Thr

C22H40N6O8S (548.2628)

peruvoside

C30H44O9 (548.2985)

D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002301 - Cardiac Glycosides C - Cardiovascular system > C01 - Cardiac therapy > C01A - Cardiac glycosides D002317 - Cardiovascular Agents

C26H52O4Sn (548.2887)

belfosdil

C27H50O7P2 (548.3032)

C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D050071 - Bone Density Conservation Agents > D004164 - Diphosphonates C93038 - Cation Channel Blocker

2-hydroxypropyl 2-methylprop-2-enoate,2-methylidenehexanoic acid,methyl 2-methylprop-2-enoate,prop-2-enoic acid,styrene

C30H44O9 (548.2985)

butyl prop-2-enoate,2-hydroxyethyl 2-methylprop-2-enoate,methyl 2-methylprop-2-enoate,2-methylprop-2-enoic acid,styrene

C30H44O9 (548.2985)

Methyl pyropheophorbide-a

MPPa (Methyl pyropheophorbide-a)

C34H36N4O3 (548.2787)

o,o-bis(4-tert-butylbenzoyl)-n,n-diallyl-l-tartardiamide

C32H40N2O6 (548.2886)

Murabutide

CID 13996209

C23H40N4O11 (548.2693)

D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents D007155 - Immunologic Factors

Imazamethabenz

C30H36N4O6 (548.2635)

Herbicidal metabolite of imazamethabenz-methyl. Acetolactate synthase inhibitor

Ajugamarin A 1

C29H40O10 (548.2621)

[(1R,3S,4R,4aR,5S,7R,8S,8aR)-8-[(3aS,5S,6aS)-3a,4,5,6a-tetrahydrofuro[2,3-b]furan-5-yl]-5-acetyloxy-4a-(acetyloxymethyl)-3-hydroxy-7,8-dimethylspiro[2,3,5,6,7,8a-hexahydro-1H-naphthalene-4,2-oxirane]-1-yl] (E)-2-methylbut-2-enoate

[(1R,3S,4R,4aR,5S,7R,8S,8aR)-8-[(3aS,5S,6aS)-3a,4,5,6a-tetrahydrofuro[2,3-b]furan-5-yl]-5-acetyloxy-4a-(acetyloxymethyl)-3-hydroxy-7,8-dimethylspiro[2,3,5,6,7,8a-hexahydro-1H-naphthalene-4,2-oxirane]-1-yl] (E)-2-methylbut-2-enoate

C29H40O10 (548.2621)

Citrinin

Antimycin A

C28H40N2O9 (548.2734)

Citrinin is practically insoluble (in water) and an extremely strong acidic compound (based on its pKa). Citrinin can be found in barley and common wheat, which makes citrinin a potential biomarker for the consumption of these food products. Citrinin is a mycotoxin which is often found in food. It is a secondary metabolite produced by fungi that contaminate long-stored food and it causes different toxic effects, like nephrotoxic, hepatotoxic and cytotoxic effects. Citrinin is mainly found in stored grains, but sometimes also in fruits and other plant products .

3-(3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl)oxy-14-hydroxy-13-methyl-17-(5-oxo-2H-furan-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthrene-10-carbaldehyde

C30H44O9 (548.2985)

Tamoxifen-N-glucuronide

(2R,3R,4S,5S,6S)-6-carboxy-N-(2-{4-[(1Z)-1,2-diphenylbut-1-en-1-yl]phenoxy}ethyl)-3,4,5-trihydroxy-N,N-dimethyloxan-2-aminium

C32H38NO7+ (548.2648)

[(2R,6S,7R,8R)-3-[(3-formamido-2-hydroxybenzoyl)amino]-8-hexyl-2,6-dimethyl-4,9-dioxo-1,5-dioxonan-7-yl] 3-methylbutanoate

C28H40N2O9 (548.2734)

D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents D000890 - Anti-Infective Agents > D000935 - Antifungal Agents

Rhamnosyl tricyclic spinosyn pseudoaglycone

C30H44O9 (548.2985)

Rhamnosyl tetracyclic spinosyn pseudoaglycone

C30H44O9 (548.2985)

3-[(21S,22S)-16-ethenyl-11,26-diethyl-4-hydroxy-12,17,21-trimethyl-7,23,24,25-tetrazahexacyclo[18.2.1.15,8.110,13.115,18.02,6]hexacosa-1,3,5,8(26),9,11,13(25),14,16,18(24),19-undecaen-22-yl]propanoic acid

3-[(21S,22S)-16-ethenyl-11,26-diethyl-4-hydroxy-12,17,21-trimethyl-7,23,24,25-tetrazahexacyclo[18.2.1.15,8.110,13.115,18.02,6]hexacosa-1,3,5,8(26),9,11,13(25),14,16,18(24),19-undecaen-22-yl]propanoic acid

C34H36N4O3 (548.2787)

Butyl 2-[2-[2-(2-acetamido-4,5,6-trihydroxy-1-oxohexan-3-yl)oxypropanoylamino]propanoylamino]-5-amino-5-oxopentanoate

C23H40N4O11 (548.2693)

3-methylbutanoic acid [(2R,6S,7R,8R)-3-[[(3-formamido-2-hydroxyphenyl)-oxomethyl]amino]-8-hexyl-2,6-dimethyl-4,9-dioxo-1,5-dioxonan-7-yl] ester

C28H40N2O9 (548.2734)

C29H40O10 (548.2621)

(2r,3'r,4'ar,5's,6'r,6'ar,10'ar,10'br)-5'-(acetyloxy)-6'a-[(acetyloxy)methyl]-4'a,10'b-dimethyl-5''-oxo-octahydrodispiro[oxirane-2,7'-naphtho[2,1-b]pyran-3',3''-oxolan]-6'-yl (2e)-2-methylbut-2-enoate

4-[(1r,3s,5s,7s,10s,11r,14r,15r,18r)-7-{[(2r,3r,4r,5s,6s)-3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-18-hydroxy-10,14-dimethyl-2-oxapentacyclo[9.7.0.0¹,³.0⁵,¹⁰.0¹⁴,¹⁸]octadecan-15-yl]-5h-furan-2-one

C30H44O9 (548.2985)

(1s,3r,5s,7r,9r,10s,12r,14r,15s,18r,19r,20r,22s,23r)-9,10,20,22-tetrahydroxy-7,18-dimethyl-19-(5-oxo-2h-furan-3-yl)-4,6,11-trioxahexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacosane-14-carbaldehyde

(1s,3r,5s,7r,9r,10s,12r,14r,15s,18r,19r,20r,22s,23r)-9,10,20,22-tetrahydroxy-7,18-dimethyl-19-(5-oxo-2h-furan-3-yl)-4,6,11-trioxahexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacosane-14-carbaldehyde

C29H40O10 (548.2621)

4-[(1s,2s,4r,5s,6s,9s,10r,13r,15s,18s)-15-{[(2r,3r,4r,5s,6s)-3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-9-hydroxy-5,18-dimethyl-3-oxapentacyclo[8.8.0.0²,⁴.0⁵,⁹.0¹³,¹⁸]octadecan-6-yl]-5h-furan-2-one

4-[(1s,2s,4r,5s,6s,9s,10r,13r,15s,18s)-15-{[(2r,3r,4r,5s,6s)-3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-9-hydroxy-5,18-dimethyl-3-oxapentacyclo[8.8.0.0²,⁴.0⁵,⁹.0¹³,¹⁸]octadecan-6-yl]-5h-furan-2-one

anticancer cardiacglycoside pmv70p691-007

C30H44O9 (548.2985)

{"Ingredient_id": "HBIN016314","Ingredient_name": "anticancer cardiacglycoside pmv70p691-007","Alias": "NA","Ingredient_formula": "C30H44O9","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1389","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

anticancer cardiacglycoside pmv70p691-008

C30H44O9 (548.2985)

{"Ingredient_id": "HBIN016315","Ingredient_name": "anticancer cardiacglycoside pmv70p691-008","Alias": "NA","Ingredient_formula": "C30H44O9","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1390","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

(1s,3r,5r,6as,7s,8s,9r,10r,10as)-1-(acetyloxy)-9-(butanoyloxy)-5,10-dihydroxy-7,8-dimethyl-7-[(2z)-3-methylpenta-2,4-dien-1-yl]-1h,3h,5h,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-3-yl butanoate

C30H44O9 (548.2985)

(1's,2s,2'r,5'r,7's,8's,10'r,12'r)-2'-({[(2e)-5-hydroxy-3-methylpent-2-enoyl]oxy}methyl)-1',5'-dimethyl-6',9'-dioxaspiro[oxirane-2,13'-tetracyclo[8.2.1.0²,⁸.0⁵,⁷]tridecan]-12'-yl (2z,4e,6r,7r)-6,7-dihydroxyocta-2,4-dienoate

(1's,2s,2'r,5'r,7's,8's,10'r,12'r)-2'-({[(2e)-5-hydroxy-3-methylpent-2-enoyl]oxy}methyl)-1',5'-dimethyl-6',9'-dioxaspiro[oxirane-2,13'-tetracyclo[8.2.1.0²,⁸.0⁵,⁷]tridecan]-12'-yl (2z,4e,6r,7r)-6,7-dihydroxyocta-2,4-dienoate

(3s,7s,9s,10r,12s,14s,18r,19r,22r,23s)-9,10,19,22-tetrahydroxy-7,18-dimethyl-19-(5-oxo-2h-furan-3-yl)-4,6,11-trioxahexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacosane-14-carbaldehyde

(3s,7s,9s,10r,12s,14s,18r,19r,22r,23s)-9,10,19,22-tetrahydroxy-7,18-dimethyl-19-(5-oxo-2h-furan-3-yl)-4,6,11-trioxahexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacosane-14-carbaldehyde

C29H40O10 (548.2621)

(1s,3r,5s,7r,9s,10s,12r,14r,15s,17r,18s,19r,22s,23r)-9,10,17,22-tetrahydroxy-7,18-dimethyl-19-(5-oxo-2h-furan-3-yl)-4,6,11-trioxahexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacosane-14-carbaldehyde

(1s,3r,5s,7r,9s,10s,12r,14r,15s,17r,18s,19r,22s,23r)-9,10,17,22-tetrahydroxy-7,18-dimethyl-19-(5-oxo-2h-furan-3-yl)-4,6,11-trioxahexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacosane-14-carbaldehyde

C29H40O10 (548.2621)

1-(acetyloxy)-9-(butanoyloxy)-5,10-dihydroxy-7,8-dimethyl-7-(3-methylpenta-2,4-dien-1-yl)-1h,3h,5h,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-3-yl butanoate

C30H44O9 (548.2985)

(1r,3r,5s,7r,8r,9r,10s,12r,14s,15r,18r,19r,22s,23r)-8,9,10,22-tetrahydroxy-7,14,18-trimethyl-19-(5-oxo-2h-furan-3-yl)-4,6,11-trioxahexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacosan-16-one

(1r,3r,5s,7r,8r,9r,10s,12r,14s,15r,18r,19r,22s,23r)-8,9,10,22-tetrahydroxy-7,14,18-trimethyl-19-(5-oxo-2h-furan-3-yl)-4,6,11-trioxahexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacosan-16-one

(1s,3r,5s,7r,9s,10s,12r,14r,18r,19r,21r,22s)-9,10,21,22-tetrahydroxy-7,18-dimethyl-19-(5-oxo-2h-furan-3-yl)-4,6,11-trioxahexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacosane-14-carbaldehyde

(1s,3r,5s,7r,9s,10s,12r,14r,18r,19r,21r,22s)-9,10,21,22-tetrahydroxy-7,18-dimethyl-19-(5-oxo-2h-furan-3-yl)-4,6,11-trioxahexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacosane-14-carbaldehyde

C29H40O10 (548.2621)

(1s,2r,5s,6s,7s,8r,9r,12r)-12-(acetyloxy)-8-hydroxy-2,6,10,10-tetramethyl-5-{[(2e)-3-phenylprop-2-en-1-yl]oxy}-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl benzoate

C33H40O7 (548.2774)

9,10,22-trihydroxy-7-(hydroxymethyl)-18-methyl-19-(5-oxo-2h-furan-3-yl)-4,6,11-trioxahexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacosane-14-carbaldehyde

C29H40O10 (548.2621)

(1s,3r,5r,6as,7s,8s,9r,10r,10as)-1,9,10-tris(acetyloxy)-5-methoxy-7,8-dimethyl-7-[(2e)-3-methylpenta-2,4-dien-1-yl]-1h,3h,5h,6h,6ah,8h,9h,10h-naphtho[1,8a-c]furan-3-yl acetate

C29H40O10 (548.2621)

(1s,3r,5s,7r,9r,10s,12r,14r,15s,18r,19r,21r,22s,23r)-9,10,21,22-tetrahydroxy-7,18-dimethyl-19-(5-oxo-2h-furan-3-yl)-4,6,11-trioxahexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacosane-14-carbaldehyde

3-hydroxy-2-{[(2e,4e,6e,8e,10e,12e)-1-hydroxy-2,10,12-trimethyl-13-[(4r,5r)-5-methyl-2-[(1e)-2-(1h-pyrrol-2-yl)ethenyl]-4,5-dihydro-1,3-oxazol-4-yl]trideca-2,4,6,8,10,12-hexaen-1-ylidene]amino}-3-(c-hydroxycarbonimidoyl)propanoic acid

C30H36N4O6 (548.2635)

4-[(1r,3s,5s,7s,10s,11r,14r,15s,18r)-7-{[(2r,3s,4r,5s,6s)-3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-18-hydroxy-10,14-dimethyl-2-oxapentacyclo[9.7.0.0¹,³.0⁵,¹⁰.0¹⁴,¹⁸]octadecan-15-yl]-5h-furan-2-one

C30H44O9 (548.2985)

(1'r,2's,3s,5's,9'r,12's,13'r,16's,18'r)-2'-hydroxy-16'-{[(2r,4s,5r,6r)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-5-oxo-7'-oxaspiro[oxolane-3,6'-pentacyclo[10.8.0.0²,⁹.0⁵,⁹.0¹³,¹⁸]icosane]-13'-carbaldehyde

(1'r,2's,3s,5's,9'r,12's,13'r,16's,18'r)-2'-hydroxy-16'-{[(2r,4s,5r,6r)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-5-oxo-7'-oxaspiro[oxolane-3,6'-pentacyclo[10.8.0.0²,⁹.0⁵,⁹.0¹³,¹⁸]icosane]-13'-carbaldehyde

n-[(2r,3s,6s,7r,8r)-2,6-dimethyl-8-(3-methylbutyl)-7-[(4-methylpentanoyl)oxy]-4,9-dioxo-1,5-dioxonan-3-yl]-2-hydroxy-3-[(hydroxymethylidene)amino]benzenecarboximidic acid

C28H40N2O9 (548.2734)

4-[(1r,3s,5s,7s,10s,11s,14r,15r,18r)-7-{[(2s,3s,4s,5s,6s)-3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-18-hydroxy-10,14-dimethyl-2-oxapentacyclo[9.7.0.0¹,³.0⁵,¹⁰.0¹⁴,¹⁸]octadecan-15-yl]-5h-furan-2-one

4-[(1r,3s,5s,7s,10s,11s,14r,15r,18r)-7-{[(2s,3s,4s,5s,6s)-3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-18-hydroxy-10,14-dimethyl-2-oxapentacyclo[9.7.0.0¹,³.0⁵,¹⁰.0¹⁴,¹⁸]octadecan-15-yl]-5h-furan-2-one

(2s)-3-[(1r,2s,3s,4r,5s)-2,4-dihydroxy-4-methyl-3,5-bis({[(2z)-2-methylbut-2-enoyl]oxy})cyclohexyl]-1-[(2s)-3,3-dimethyloxiran-2-yl]but-3-en-2-yl (2z)-2-methylbut-2-enoate

C30H44O9 (548.2985)

4-[(1s,2s,4r,5s,6s,9s,10r,13r,15s,18s)-15-{[(2r,3s,4r,5s,6s)-3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-9-hydroxy-5,18-dimethyl-3-oxapentacyclo[8.8.0.0²,⁴.0⁵,⁹.0¹³,¹⁸]octadecan-6-yl]-5h-furan-2-one

4-[(1s,2s,4r,5s,6s,9s,10r,13r,15s,18s)-15-{[(2r,3s,4r,5s,6s)-3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-9-hydroxy-5,18-dimethyl-3-oxapentacyclo[8.8.0.0²,⁴.0⁵,⁹.0¹³,¹⁸]octadecan-6-yl]-5h-furan-2-one

C30H44O9 (548.2985)

3-benzyl-6,12-bis(furan-3-ylmethyl)-5,11-dihydroxy-9-isopropyl-1,7-dimethyl-1,4,7,10-tetraazacyclododeca-4,10-diene-2,8-dione

C30H36N4O6 (548.2635)